Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Eur Neuropsychopharmacol. 2020 Jun 26;40:70–84. doi: 10.1016/j.euroneuro.2020.06.004

Table 3.

KEGG pathway results from extremely upregulated 24 miRNAs (fold change cut off >2.0)

Gene Set Description Enrichment ratio p-value FDR Candidate genes
hsa04720 Long-term potentiation 3.4039 0.00016382 0.0055154 ADCY1, CALM1, GRIA2, GRIN1, MAPK1, PPP1CB, PRKCA, PRKCB, PRKCG, RAP1A, RPS6KA1, RPS6KA3
hsa05220 Chronic myeloid leukemia 3.2509 0.00014340 0.0055154 CBL, CDKN1B, GAB2, GADD45A, HDAC2, MAPK1, MYC, NFKB1, NFKBIA, PIK3CD, POLK, RELA, SHC4
hsa04550 Signaling pathways regulating pluripotency of stem cells 2.7345 0.000035245 0.0041494 ACVR1B, ACVR2B, BMPR1A, FGFR2, FZD10, FZD3, FZD5, IGF1, IL6ST, KAT6A, MAPK1, MEIS1, MYC, ONECUT1, OTX1, PCGF5, PIK3CD, SMAD9, WNT3A, ZFHX3
hsa04722 Neurotrophin signaling pathway 2.7150 0.00014818 0.0055154 ARHGDIA, CALM1, IRAK2, IRAK4, MAPK1, NFKB1, NFKBIA, NTRK2, NTRK3, PIK3CD, RAN1A, RELA, RPS6KA1, RPS6KA3, RPS6KA5, SHC4, TP73
hsa04360 Axon guidance 2.4978 0.000040804 0.0041494 ARHGEF12, CFL2, CXCL12, DPYSL5, FZD3, GNAI2, MAPK1, NRP1, PAK2, PAK3, PARD6G, PIK3CD, PLXNA1, PLXNC1, PRKCA, RASA1, ROBO2, ROCK1, SEMA3A, SEMA3C, SEMA5A, SRGAP2, SRGAP3
hsa04014 Ras signaling pathway 2.3756 0.000010929 0.0035628 ARF6, CALM1, CSF1, FGF1, FGFR2, GAB2, GNGT2, GRIN1, IGF1, KIT, KSR2, MAPK1, NFKB1, NTRK2, PAK2, PAK3, PIK3CD, PRKCA, PRKCB, PRKCG, RAB5B, RAP1A, RASAL2, RASGRF2, RELA, SHC4, STK4, TEK
hsa05202 Transcriptional misregulation in cancer 2.3501 0.00010641 0.0055154 AFF1, CDKN1B, FOXO1, GADD45A, H3F3B, HDAC2, HMGA2, IGF1, IL2RB, KLF3, MEF2C, MEIS1, MMP3, MPO, MYC
hsa04144 Endocytosis 2.1030 0.00018487 0.0055154 AGAP1, ARF6, ARFGEF1, CAPZA1, CBL, CHMP4C, CHMP7, CYTH4, FGFR2, IL2RB, IQSEC2, KIF5C, NEDD4, PARD6G, PIP5K1C, PML, PRKCI, RAB10, RAB11FIP4, RAB31, RAB35, RAB5B, RABEP1, SH3GLB1, SMURF1, SNX12, STAM2
hsa04010 MAPK signaling pathway 1.9971 0.00016207 0.0055154 CACNA1E, CACNB4, CSF1, DUSP16, FGF1, FGFR2, CADD45A, IGF1, IRAK4, KIT, MAPK1, MEF2C, MKNK2, MYC, NFKB1, NLK, NTRK2, PAK2, PRKCA, PRKCB, PRKCG, RAP1A, RASA1, RASGRF2, RELA, RPS6KA1, RPS6KA3, RPS6KA5, STK4, TAOK1, TEK
hsa05200 Pathways in cancer 1.7704 0.000050912 0.0041494 ADCY1, ADCY2, ARHGEF12, ARNT, CALM1, CBL, CCDC6, CDKN1B, COL4A2, CXCL12, DLL4, EDNRB, ESR1, FGF1, FGFR2, FOXO1, FZD10, FZD3, FZD5, GADD45Am GNAI2, GNGT2, HDAC2, HEY2, IGF1, IL2RB, IL6ST, ITGA2, KIT, LAMC3, MAPK1, MYC, NFKB1, NFKBIA, NOTCH2, PIK3CD, PML, POLK, PRKCA, PRLCB, PRKCG, RELA, ROCK1, RPS6KA5, SP1, STK4, TPM3, TRAF4, WNT3A